Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis-Reference-Cited by-同舟云学术

Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis

Published:2016-05-26 Issue:6 Volume:68 Page:1346-1352
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Gottenberg J. E.¹,Courvoisier D. S.²,Hernandez M. V.³^ORCID,Iannone F.⁴,Lie E.⁵,Canhão H.⁶,Pavelka K.⁷,Hetland M. L.⁸,Turesson C.⁹,Mariette X.¹⁰,Finckh A.²

Affiliation:

1. Strasbourg University Hospital and University of Strasbourg, CNRS, Institut de Biologie Moléculaire et Cellulaire, Immunopathologie, et Chimie Thérapeutique; Strasbourg France

2. University of Geneva and University Hospital of Geneva; Geneva Switzerland

3. Hospital Clinic of Barcelona and IDIBAPS; Barcelona Spain

4. University of Bari and University Hospital; Bari Italy

5. Diakonhjemmet Hospital; Oslo Norway

6. University of Lisbon and Santa Maria Hospital; Lisbon Portugal

7. Institute of Rheumatology and University Hospital; Prague Czech Republic

8. DANBIO Registry and University of Copenhagen, Copenhagen, Denmark, and Rigshospitalet; Glostrup Denmark

9. Lund University and Skåne University Hospital; Malmö Sweden

10. Université Paris-Sud, Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, AP-HP, and INSERM U1184; Le Kremlin Bicêtre France

Funder

Bristol Myers-Squibb

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.39595/fullpdf

Reference22 articles.

1. Anti-CCP antibodies: the past, the present and the future;Venrooij;Nat Rev Rheumatol,2011

2. Redefining the HLA and RA association: to be or not to be anti-CCP positive;Vries;J Autoimmun,2005

3. Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis;Snir;Arthritis Res Ther,2014

4. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis;Helm-van Mil;Arthritis Res Ther,2005

5. Consistent inhibition of structural damage progression by rituximab in medically important subgroups of patients with an inadequate response to TNF inhibitors: week 56 REFLEX results [abstract];Cohen;Arthritis Rheum,2007

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis;Arthritis Research & Therapy;2024-03-05

2. Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies;Joint Bone Spine;2024-03

3. The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials;Rheumatology;2024-02-16

4. Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioReg;Arthritis Research & Therapy;2024-02-08

5. Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis;Rheumatology;2024-02-06